Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Using COR ECG Wearable Monitor

NCT06699056 is registered in ClinicalTrials.gov with Peerbridge Health, Inc as lead sponsor.

NCT NCT06699056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06699056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Using COR ECG Wearable Monitor
Lead sponsor
Peerbridge Health, Inc
Phase
Observational
Overall status
Recruiting
Start date
November 21, 2024
Completion date
November 15, 2027
Enrollment
2,000 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

atrial enlargement, cardiotoxicity, conduction defect, dilated cardiomyopathy, heart failure, hfpef - heart failure with preserved ejection fraction, hfref - heart failure with reduced ejection fraction, ischemic heart disease, lv dysfunction, lvf, myocardial infarction, remodeling, cardiac, syncope, valvular heart disease, ventricular ejection fraction